In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 35857-89-7, name is 6-Chloropyridazine-3-carbonitrile, introducing its new discovery. HPLC of Formula: C5H2ClN3
POTASSIUM CHANNEL INHIBITORS
The present invention relates to dipyridin-3-ylmethoxy compounds and derivatives thereof having the structure I useful as potassium channel inhibitors to treat cardiac arrhythmias, and the like.
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 35857-89-7, and how the biochemistry of the body works.HPLC of Formula: C5H2ClN3
Reference£º
Pyridazine – Wikipedia,
Pyridazine | C4H4N890 – PubChem